Back to Search
JOSEPH KASSA, D.O.
D.O.
Neurology Physician
NPI: 1548672397IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
5101020940(MI)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 2014
Research & Publications (20)
An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
PMID 18686075·Clin Toxicol (Phila)·2009
7-preclinical
A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats.
PMID 19514949·Drug Chem Toxicol·2009
7-preclinical
A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
PMID 19552519·J Enzyme Inhib Med Chem·2009
4-observational
Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
PMID 19143747·Basic Clin Pharmacol Toxicol·2009
4-observational
An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
PMID 18054821·Toxicology·2008
4-observational
A comparison of the neuroprotective efficacy of newly developed oximes (K156, K203) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
PMID 19453087·Acta Medica (Hradec Kralove)·2008
4-observational
The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun.
PMID 18855728·Mini Rev Med Chem·2008
6-review
A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
PMID 18547554·Chem Biol Interact·2008
4-observational
A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice.
PMID 18608751·J Enzyme Inhib Med Chem·2008
4-observational
A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.
PMID 18161512·Drug Chem Toxicol·2008
4-observational
Effect of several new and currently available oxime cholinesterase reactivators on tabun-intoxicated rats.
PMID 19330072·Int J Mol Sci·2008
8-other
A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
PMID 18622871·Drug Chem Toxicol·2008
4-observational
A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
PMID 17674811·J Enzyme Inhib Med Chem·2007
4-observational
The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats.
PMID 17710615·J Toxicol Environ Health A·2007
7-preclinical
A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats.
PMID 17454028·Drug Chem Toxicol·2007
4-observational
Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats.
PMID 17910616·Basic Clin Pharmacol Toxicol·2007
4-observational
A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
PMID 17141392·Toxicology·2007
4-observational
A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
PMID 16952906·J Toxicol Environ Health A·2006
4-observational
Therapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL.
PMID 17265682·Arh Hig Rada Toksikol·2006
6-review
The influence of oxime and anticholinergic drug selection on the potency of antidotal treatment to counteract acute toxic effects of tabun in mice.
PMID 16464753·Neurotox Res·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 28595 ORCHARD LAKE RD STE 200
FARMINGTON HILLS, MI 48334 - Phone
- (248) 553-0010
Quick Facts
- NPI
- 1548672397
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile